	Los Gastos De Explotación		Fecha
Agios Pharmaceuticals	USD 141.54M	11.8M	2025-12
Alnylam Pharmaceuticals	USD 965.32M	84.27M	2025-12
Arrowhead Research	USD 223.22M	10.86M	2025-12
Astellas Pharma	JPY 436.66B	16.75B	2025-12
BioCryst Pharmaceuticals	USD -387.89M	33.7M	2025-09
BioMarin Pharmaceutical	USD 676.18M	131.65M	2025-12
Celltrion	KRW 724.99B	6B	2025-09
Cspc Pharmaceutical	CNY 5.4B	298.41M	2025-09
Deva Holding AS	TRY 1.35B	178.26M	2023-09
Divis Laboratories Ltd	INR 18.32B	1.08B	2025-12
Esperion Therapeutics	USD 67.66M	3.6M	2024-09
Exelixis	USD 362.75M	21.35M	2025-12
Halozyme Therapeutics	USD 211.07M	74.73M	2025-12
Ionis Pharmaceuticals	USD 316.9M	4.69M	2025-09
Kangmei Pharma	CNY 1.39B	144.29M	2025-09
Knight Therapeutics	CAD 89.06M	2.02M	2024-09
Laboratorios Farma	EUR 313.62M	17.98M	2023-12
Malin Corporation	EUR 1.1M	400K	2024-12
Medical Developments International	AUD 10.02M	9.78M	2025-06
Moderna	USD 1.54B	259M	2025-12
Nektar Therapeutics	USD 85.09M	109.3M	2025-09
Neuren Pharmaceuticals	AUD 8.69M	8.72M	2025-06
Neurocrine Biosciences	USD 577.6M	22M	2025-12
Novartis	USD 9.86B	115M	2025-09
Omeros	USD 59.16M	20.13M	2024-06
OPKO Health	USD 205.19M	11.6M	2025-09
Organigram Holdings	CAD 108.11M	17.03M	2025-09
Ovoca Bio	EUR 5.65M	3.45M	2022-06
Pfizer	USD 12.91B	79.89B	2025-12
Pharma Mar	EUR 39.62M	7.34M	2025-09
PTC Therapeutics	USD 246.3M	38.78M	2025-12
Qiagen NV	USD 418.54M	23.25M	2025-12
Regeneron Pharmaceuticals	USD 2.99B	27.97B	2025-12
Roche Holding	CHF 21.01B	10.84B	2025-12
Sarepta Therapeutics	USD 462.23M	33.28M	2025-09
Sartorius	EUR 693.1M	29.4M	2025-09
Sino Biopharmaceutical	CNY 12.39B	1.26B	2025-06
Tilray	USD 237.52M	17.34M	2025-09
Ultragenyx Pharmaceutical	USD 321M	9.82M	2025-12
Vertex Pharmaceuticals	USD 1.93B	89.1M	2025-12
Zz Pientze Pharmaceu	CNY 1.55B	129.66M	2025-09

Ionis Pharmaceuticals Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.